Human LAPTM4B activation kit by CRISPRa
CAT#: GA110731
LAPTM4B CRISPRa kit - CRISPR gene activation of human lysosomal protein transmembrane 4 beta
CNY 12255.00
Specifications
| Product Data | |
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
| Symbol | LAPTM4B |
| Locus ID | 55353 |
| Kit Components | GA110731G1, LAPTM4B gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA110731G2, LAPTM4B gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA110731G3, LAPTM4B gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
| Reference Data | |
| RefSeq | NM_018407 |
| Synonyms | LAPTM4beta; LC27 |
| Summary | Required for optimal lysosomal function (PubMed:21224396). Blocks EGF-stimulated EGFR intraluminal sorting and degradation. Conversely by binding with the phosphatidylinositol 4,5-bisphosphate, regulates its PIP5K1C interaction, inhibits HGS ubiquitination and relieves LAPTM4B inhibition of EGFR degradation (PubMed:25588945). Recruits SLC3A2 and SLC7A5 (the Leu transporter) to the lysosome, promoting entry of leucine and other essential amino acid (EAA) into the lysosome, stimulating activation of proton-transporting vacuolar (V)-ATPase protein pump (V-ATPase) and hence mTORC1 activation (PubMed:25998567). Plays a role as negative regulator of TGFB1 production in regulatory T cells (PubMed:26126825). Binds ceramide and facilitates its exit from late endosome in order to control cell death pathways (PubMed:26280656).[UniProtKB/Swiss-Prot Function] |
Documents
Resources
| 基因表达相关资源 |
Other Versions
| SKU | Description | Size | Price |
|---|---|---|---|
| KN407325 | LAPTM4B - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8680.00 |
其它LAPTM4B产品
